News

Filter

Current filters:

None

7960 to 7969 of 96563 results

Pfizer sells Nutrition business to Nestle for $11.85 billion

24-04-2012

Swiss food giant Nestle has won the battle to acquire the Nutrition business of global drugs behemoth…

Mergers & AcquisitionsNestlePfizerPharmaceutical

Stada Arz viewing optimization of Russian operations

23-04-2012

German pharmaceutical producer Stada Arzneimittel is considering optimizing its Russian operations through…

EuropeFinancialGenericsMarkets & MarketingPharmaceuticalSTADA Arzneimittel

PhRMA firms have nearly 300 therapeutic vaccines in development

23-04-2012

US research-based biopharmaceutical companies are developing nearly 300 vaccines for the prevention and…

BiotechnologyNorth AmericaPharmaceuticalResearchVaccines

Par Pharma acquires Handa's ANDA for generic Dexilant

23-04-2012

USA-based Par Pharmaceutical (NYSE: PRX) has entered into an exclusive acquisition and license agreement…

DexilantGastro-intestinalsGenericsHanda PharmaceuticalsLicensingNorth AmericaPar PharmaceuticalsTakeda Pharmaceuticals

Struggling pharma companies to outsource clinical trial research

23-04-2012

Falling revenue in some healthcare sectors means companies are making huge efforts to reduce R&D expenditure…

Markets & MarketingPharmaceuticalResearch

FDA strengthens monitoring of post-approval drug safety

23-04-2012

In what is seen as a response to criticism that the agency lacks teeth in monitoring drugs once they…

BiotechnologyMarkets & MarketingNorth AmericaPharmaceuticalRegulation

Positive Ph III results for Novo Nordisk's degludec; US advocacy calls for Victoza's withdrawal

23-04-2012

Danish diabetes specialist Novo Nordisk (NOV: N) says that its investigational ultra-long-acting insulin…

DegludecDiabetesNorth AmericaNovo NordiskPharmaceuticalRegulationResearchVictoza

7960 to 7969 of 96563 results

Back to top